Anchiano Therapeutics Ltd (BICL):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Anchiano Therapeutics Ltd (BICL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9794
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Anchiano Therapeutics Ltd (Anchiano) formerly BioCancell Ltd, focuses on the identification, development and commercialization of therapies for diagnosis and treatment of cancer-related diseases such as superficial bladder carcinoma, pancreatic cancer and ovarian cancer. The company’s product pipeline candidates is being evaluated for the treatment of bladder cancer, ovarian cancer and pancreatic cancer. The company develops its products based on its proprietary, personalized cancer therapy approach H19, which plays a key role in the development, progress, drug resistance and metastasis of most human cancers. Anchiano is headquartered at Jerusalem, Israel.

Anchiano Therapeutics Ltd (BICL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Anchiano Therapeutics Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Anchiano Therapeutics (BioCancell) Files Draft Registration Statement for Public Offering 11
BioCancell Raises USD23 Million in Private Placement of Shares 12
BioCanCell to Raise up to USD25 Million in Private Placement of shares 13
Biocancell Therapeutics to Raise USD6 Million in Private Placement of Shares 14
BioCancell Therapeutics Announces Rights Offering Of Shares For US$2.6 Million 15
BioCancell Therapeutics Completes Public Offering Of Shares For US$4.75 Million 16
BioCancell Therapeutics Announces Public Offering Of Shares For US$4 Million 17
Anchiano Therapeutics Ltd – Key Competitors 18
Anchiano Therapeutics Ltd – Key Employees 19
Anchiano Therapeutics Ltd – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Financial Announcements 21
Aug 22, 2018: BioCanCell announces second quarter 2018 financial results 21
Corporate Communications 22
Aug 30, 2018: Anchiano Therapeutics appoints Efrat Makov to its board of directors 22
Mar 07, 2018: BioCanCell Announces Two New Hires in Clinical Development and Clinical Operations 23
Aug 14, 2017: BioCanCell Announces Appointment of Ms. Ruti Alon to Board of Directors 24
Clinical Trials 25
Nov 15, 2017: BioCanCell Announces Updated Results from the Phase 2 Clinical Trial of BC-819 and BCG in Patients with Bladder Cancer 25
Other Significant Developments 26
Aug 27, 2018: BioCanCell announces company name change to Anchiano Therapeutics 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anchiano Therapeutics Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Anchiano Therapeutics Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Anchiano Therapeutics (BioCancell) Files Draft Registration Statement for Public Offering 11
BioCancell Raises USD23 Million in Private Placement of Shares 12
BioCanCell to Raise up to USD25 Million in Private Placement of shares 13
Biocancell Therapeutics to Raise USD6 Million in Private Placement of Shares 14
BioCancell Therapeutics Announces Rights Offering Of Shares For US$2.6 Million 15
BioCancell Therapeutics Completes Public Offering Of Shares For US$4.75 Million 16
BioCancell Therapeutics Announces Public Offering Of Shares For US$4 Million 17
Anchiano Therapeutics Ltd, Key Competitors 18
Anchiano Therapeutics Ltd, Key Employees 19
Anchiano Therapeutics Ltd, Other Locations 20
Anchiano Therapeutics Ltd, Subsidiaries 20

List of Figures
Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Anchiano Therapeutics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Anchiano Therapeutics Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Anchiano Therapeutics Ltd (BICL):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cooper Energy Ltd (COE):石油・ガス:M&Aディール及び事業提携情報
    Summary Cooper Energy Limited (CEL) is an exploration and production company that offers oil production programs. The company explores, produces, and commercializes crude oil and natural gas products. It conducts exploration for oil and gas through a portfolio of prospective acreage in the Cooper, O …
  • Zhejiang Hisun Pharmaceutical Co Ltd (600267):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Hisun Pharmaceutical Co Ltd (Hisun) is a pharmaceutical company that manufactures and commercializes active pharmaceutical ingredients, antibiotics and anticancer drugs. The company offers active pharmaceutical ingredients and bulk drugs used in anti-neoplastics. It offers products …
  • Energy Transfer Partners, L.P.:企業の戦略・SWOT・財務情報
    Energy Transfer Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Energy Transfer Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Cathedral Energy Services Ltd (CET):企業の財務・戦略的SWOT分析
    Summary Cathedral Energy Services Ltd (Cathedral) is an oil and gas company that provides drilling and completion services. The company's services include horizontal and directional drilling services, flowback and production testing, production testing services, measurement while drilling services a …
  • PanAust Ltd:企業の戦略・SWOT・財務情報
    PanAust Ltd - Strategy, SWOT and Corporate Finance Report Summary PanAust Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Oaktree Capital Group LLC:企業の戦略・SWOT・財務情報
    Oaktree Capital Group LLC - Strategy, SWOT and Corporate Finance Report Summary Oaktree Capital Group LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Vornado Realty Trust:企業の戦略・SWOT・財務分析
    Vornado Realty Trust - Strategy, SWOT and Corporate Finance Report Summary Vornado Realty Trust - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Unum Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Unum Therapeutics Inc (Unum) is a cancer cell therapy company that discovers, develops, and commercializes novel antibody-coupled cellular immunotherapies. The company uses its proprietary Antibody-Coupled T-cell Receptor (ACTR) technology for discovering and developing new cellular immunoth …
  • Genesis Energy:戦略・SWOT・企業財務分析
    Genesis Energy - Strategy, SWOT and Corporate Finance Report Summary Genesis Energy - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Beach Energy Limited:企業の戦略・SWOT・財務分析
    Beach Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Beach Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ko Yo Chemical (Group) Ltd (827):企業の財務・戦略的SWOT分析
    Ko Yo Chemical (Group) Ltd (827) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • IXICO Plc (IXI)-製薬・医療分野:企業M&A・提携分析
    Summary IXICO Plc (IXICO), formerly Phytopharm plc is a provider of clinical trial services and technology for the evaluation of imaging endpoints. The company provides clinical trial services for assessing the safety and efficacy of drugs. Its product portfolio includes web-based platform to transf …
  • Santos Limited:企業の戦略・SWOT・財務分析
    Santos Limited - Strategy, SWOT and Corporate Finance Report Summary Santos Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • TransMontaigne Product Services LLC:戦略・SWOT・企業財務分析
    TransMontaigne Product Services LLC - Strategy, SWOT and Corporate Finance Report Summary TransMontaigne Product Services LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • MedX Health Corp (MDX):医療機器:M&Aディール及び事業提携情報
    Summary MedX Health Corp (MedX) is a medical device company that designs, manufactures and distributes phototherapeutic devices. The company’s phototherapy products include rehab laser console system, acupuncture portable laser console system, rehab portable laser, oralase portable laser probe, and …
  • Bega Cheese Ltd:企業のM&A・事業提携・投資動向
    Bega Cheese Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bega Cheese Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Stock Spirits Group PLC:企業の戦略・SWOT・財務情報
    Stock Spirits Group PLC - Strategy, SWOT and Corporate Finance Report Summary Stock Spirits Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • iRobot Corp (IRBT):企業の財務・戦略的SWOT分析
    iRobot Corp (IRBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Jetion Solar (China) Co Ltd:電力:M&Aディール及び事業提携情報
    Summary Jetion Solar (China) Co Ltd (Jetion Solar), a subsidiary of China National Building Material Company Ltd, is an alternative energy company that manufactures solar modules and solar power plants. The company offers solar systems, solar panels, polycrystalline panels, monocrystalline panels, a …
  • The Council of Europe Development Bank:企業の戦略・SWOT・財務情報
    The Council of Europe Development Bank - Strategy, SWOT and Corporate Finance Report Summary The Council of Europe Development Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆